Livzon Pharmaceutical Group Inc. (000513.SZ)
CNY 37.67
(-0.34%)
CNY 37.67
(-0.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.39 Billion | 2.77 Billion | 1.9 Billion | 2.16 Billion | 1.76 Billion | 1.26 Billion |
| Net Income | 1.95 Billion | 1.95 Billion | 1.95 Billion | 2.13 Billion | 1.46 Billion | 1.18 Billion |
| Depreciation & Amortization | 866.37 Million | 652.32 Million | 445.27 Million | 394.29 Million | 384.61 Million | 364.1 Million |
| Deferred income taxes | -13.36 Million | 2.42 Million | 15.48 Million | -39.35 Million | -20.98 Million | 11.54 Million |
| Stock-based compensation | 76.72 Million | 47.32 Million | 32.73 Million | 31.43 Million | 16.71 Million | 3.4 Million |
| Change in working capital | 16.15 Million | -121.64 Million | -653.19 Million | -406.58 Million | -197.12 Million | -371.52 Million |
| Other non-cash items | 2.28 Billion | 236.71 Million | 109.93 Million | 49.62 Million | 122.37 Million | 93.32 Million |
| Investing Cash Flow | -777.11 Million | -1.22 Billion | -1.87 Billion | -467.84 Million | -316.02 Million | -1.02 Billion |
| Investments in PPE | -820.45 Million | -940.14 Million | -1.3 Billion | -646.97 Million | -397.99 Million | -474.47 Million |
| Acquisitions | 68.53 Million | 2.95 Million | 3.31 Million | 5.33 Million | 1.85 Million | 24.74 Million |
| Investment purchases | -473.15 Million | -399.18 Million | -786 Million | -129.18 Million | -126.12 Million | -555.97 Million |
| Sales/Maturities of investments | 471.56 Million | 130.68 Million | 208.68 Million | 273.28 Million | 136.14 Million | 37 Million |
| Other Investing Activities | -23.59 Million | -24.18 Million | 6.2 Million | 29.69 Million | 70.09 Million | -52.15 Million |
| Financing Cash Flow | -1.73 Billion | -720.35 Million | -815.01 Million | -518.04 Million | -1.18 Billion | 857.42 Million |
| Debt repayment | -531.83 Million | -2.8 Billion | -2.03 Billion | -1.82 Billion | -1.65 Billion | -300 Million |
| Dividends payments | -1.48 Billion | -1.21 Billion | -1.16 Billion | -1.07 Billion | -862.85 Thousand | -1.12 Billion |
| Common Stock Repurchased | -346.15 Million | -56.03 Million | -238.18 Million | -250.06 Million | -25.2 Thousand | - |
| Common Stock Issuance | -23.54 Million | 56.03 Million | 238.18 Million | 250.06 Million | 25.2 Thousand | 637.59 Million |
| Other Financing Activities | -407.98 Million | 3.38 Billion | 2.47 Billion | 2.41 Billion | 1.33 Billion | 1.64 Billion |
| Accounts receivables | 466.28 Million | -660.45 Million | -664.68 Million | -491.92 Million | -81.1 Million | 141.37 Million |
| Accounts payables | -115.71 Million | 1.03 Billion | 228.01 Million | 525.04 Million | 13.3 Million | -427.29 Million |
| Inventory | -334.42 Million | -498.57 Million | -232 Million | -400.34 Million | -108.33 Million | -97.14 Million |
| Other working capital | -2.00 | 2.42 Million | 15.48 Million | -39.35 Million | -20.98 Million | -274.37 Million |
| Cash at beginning of period | 10.41 Billion | 9.12 Billion | 9.95 Billion | 8.85 Billion | 8.56 Billion | 7.4 Billion |
| Cash at end of period | 11.32 Billion | 10.07 Billion | 9.12 Billion | 9.95 Billion | 8.85 Billion | 8.56 Billion |
| Capital Expenditure | -820.45 Million | -940.14 Million | -1.3 Billion | -646.97 Million | -397.99 Million | -474.47 Million |
| Effect of forex changes on cash | 20.04 Million | 124.88 Million | -37.15 Million | -77.01 Million | 20.41 Million | 58.53 Million |
| Net cash flow / Change in cash | 914.37 Million | 947.33 Million | -826.74 Million | 1.09 Billion | 290.47 Million | 1.16 Billion |
| Free Cash Flow | 2.57 Billion | 1.83 Billion | 593.22 Million | 1.51 Billion | 1.36 Billion | 793.14 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 501.76 Million | 563.14 Million | 607.82 Million | 352.09 Million | 1.95 Billion | 466.98 Million |
| Depreciation & Amortization | - | 169.9 Million | 169.9 Million | 176.58 Million | 866.37 Million | -473 Million |
| Deferred income taxes | - | - | - | -285.31 Million | -13.36 Million | -94.17 Million |
| Stock-based compensation | - | 15.07 Million | - | 76.72 Million | 76.72 Million | -37.04 Million |
| Change in working capital | - | -235.48 Million | - | 208.58 Million | 16.15 Million | 560.77 Million |
| Other non-cash items | 281.96 Million | 213.7 Million | 322.25 Million | 582.99 Million | 2.28 Billion | 561.55 Million |
| Investing Cash Flow | -404.14 Million | 233 Million | -457.33 Million | -192.29 Million | -777.11 Million | -116.83 Million |
| Investments in PPE | -135.05 Million | -114.55 Million | -155.62 Million | -265.8 Million | -820.45 Million | -155.58 Million |
| Acquisitions | 187.47 Thousand | 31.8 Thousand | 201.34 Thousand | 44.37 Million | 68.53 Million | 7.32 Million |
| Investment purchases | -308.55 Million | -56.74 Million | -307.54 Million | -65.51 Million | -473.15 Million | 58.02 Thousand |
| Sales/Maturities of investments | 39.74 Million | 404.07 Million | 5.83 Million | 97.22 Million | 471.56 Million | 43.44 Million |
| Other Investing Activities | -286.08 Thousand | 202.36 Thousand | -202.36 Thousand | -2.57 Million | -23.59 Million | -12.07 Million |
| Financing Cash Flow | -1.1 Billion | -151.12 Million | -654.61 Million | 74.13 Million | -1.73 Billion | -1.35 Billion |
| Debt repayment | -62.64 Million | -473.85 Million | -577.06 Million | -131.01 Million | -531.83 Million | -1.11 Billion |
| Dividends payments | -927.63 Million | -370.2 Million | -22.79 Million | -904.55 Million | -1.48 Billion | -903.33 Million |
| Common Stock Repurchased | 135.51 Million | -135.51 Million | - | -346.15 Million | -346.15 Million | 142.66 Million |
| Common Stock Issuance | - | - | - | -23.54 Million | -23.54 Million | -142.66 Million |
| Other Financing Activities | -241.52 Million | -477.06 Million | -53.73 Million | 1.21 Billion | -407.98 Million | 663 Million |
| Accounts receivables | - | -308.49 Million | - | 466.28 Million | 466.28 Million | 317.88 Million |
| Accounts payables | - | - | - | - | -115.71 Million | 37.04 Million |
| Inventory | - | 57.93 Million | - | -334.42 Million | -334.42 Million | 242.88 Million |
| Other working capital | - | 15.07 Million | - | 76.72 Million | -2.00 | -37.04 Million |
| Cash at beginning of period | 11.48 Billion | 11.14 Billion | 10.97 Billion | 10.35 Billion | 10.41 Billion | 10.48 Billion |
| Cash at end of period | 10.72 Billion | 11.49 Billion | 10.78 Billion | 11.32 Billion | 11.32 Billion | 9.99 Billion |
| Capital Expenditure | -135.05 Million | -114.55 Million | -155.62 Million | -265.8 Million | -820.45 Million | -155.58 Million |
| Effect of forex changes on cash | -24.22 Million | 3.56 Million | -690.19 Thousand | -12.99 Million | 20.04 Million | 1.05 Million |
| Net cash flow / Change in cash | -757 Million | 355.18 Million | -188.39 Million | 969.6 Million | 914.37 Million | -489.08 Million |
| Free Cash Flow | 648.66 Million | 492.38 Million | 774.45 Million | 845.86 Million | 2.57 Billion | 829.51 Million |
016450
LTI
5351
6928
ALPP
0H14